on EXASOL AG (isin : DE000A0LR9G9)
Exasol's Stable ARR Amid Challenges in Revenue Growth
Exasol AG reported stable Annual Recurring Revenue (ARR) at EUR 37.9 million in Q3 2026, nearly matching the prior year's level. Despite a decline in revenue from EUR 31.7 million to EUR 28.7 million in the first nine months, the company confirmed its 2026 guidance. New customers and a reduction in churn were positive trends, but weaker upselling with existing clients impacted overall revenue growth.
Exasol's strategy in focus industries is yielding results, with new ARR reaching EUR 26.9 million as of September 2026. Notably, a Fortune 500 pharmaceutical company became a new customer, marking a significant milestone for Exasol's agentic AI strategy. The company expects further expansion with this relationship going into 2027.
Partnership developments were also pivotal. Collaborations with adesso and MariaDB have progressed, with the commercial launch of the MariaDB Exa product. Exasol targets a revitalization of ARR momentum through enhanced data sovereignty solutions, amidst global geopolitical concerns.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EXASOL AG news